StockWatch
·
Pharmaceuticals
Quarterly Result29 May 2026, 10:51 pm

Gujarat Terce Labs: FY26 Revenue ₹47.81 Cr

AI Summary

Gujarat Terce Laboratories Ltd announced audited standalone financial results for the fourth quarter and financial year ended March 31, 2026. The Board of Directors approved the results in a meeting held on May 29, 2026. The company's revenue from operations for FY26 stood at ₹47.81 Cr. The audit report, issued by Shah Doshi Patel & Associates LLP, has an unmodified opinion. The company operates in the pharmaceutical segment.

Key Highlights

  • Gujarat Terce Labs' FY26 revenue from operations is ₹47.81 Cr.
  • The Board approved audited standalone financial results on May 29, 2026.
  • Shah Doshi Patel & Associates LLP issued an unmodified audit report.
  • The company's Board meeting concluded at 8:31 p.m. (IST).